Cardiology

Clinicians have indicated which symptom subtypes are associated with a greater risk of cardiovascular conditions in patients with OSA.

The new device will treat patients who are not suited for other commonly used treatment options for advanced heart failure.

Children and adolescents have considerably fewer control therapy options for T2D. The GLP-1 agonist could be the first of its class for pediatric indication.

The TAVR treatment was associated with a 46% reduction in one-year event risk among patients at low risk of open heart surgery.

While results of COMPASS proved the efficacy of combination rivaroxban-plus-aspirin, it may not be the best treatment for every patient suffering from coronary or peripheral artery disease.

A team of investigators review global HCV infection rates in an attempt to quantify HCV-associated cardiovascular disease.

After showing a significant impact on reduction of cardiovascular events, a slew of subgroup analyses were performed examining use of icosapent ethyl using data derived from REDUCE-IT.

The investigative monoclonal antibody from Regeneron shows significant benefit for patients with the rare, severe homozygous familial hypercholesterolemia.

Trial investigator Deepak Bhatt, MD, MPH, discusses how use of rivaroxaban in a clinical setting has changed as a result of the COMPASS trial.

Lead investigator of REDUCE-IT trials discusses the impact of trial results and what that means for EPA-based treatments going forward.

Use of rivaroxaban (Xarelto) plus aspirin was found to reduce cardiovascular and major limb events in a secondary analysis of the COMPASS trial.

How do the states with the longest-running legislation permitting MAID compare?

The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.

Stimulating the sphenopalatine ganglion-a collection of nerve cells closely associated with the trigeminal nerve most responsible for headaches-could be a safe intervention for patients with acute ischemic stroke who aren’t eligible for thrombolytic therapy, according to an article published in The Lancet last month.

A 34-year-old male with no significant past medical history presents to the emergency department with 10 hours of constant chest pain radiating into his back that started last night. What's your diagnosis?

A 22-year-old male with no significant past medical history is brought to the emergency department for syncope. He was getting a haircut when he fainted. What's your diagnosis?

Strict adherence to a plant-based diet could result in a 16% reduction in risk of having a cardiovascular disease.

An 83-year-old woman with kidney disease was brought to the ED for heart palpitations and shortness of breath. What's your diagnosis?

Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant associated with low rates of major bleeding and arterial thromboembolism in the PAUSE study.

Obesity, smoking, and other trends are slowing the rate of decline, and even causing increases, of cardiovascular disease in many high-income countries across the world.

Proof-of-concept study follows patients who receive a HCV-positive donor heart.